Sage Therapeutics Inc (DELISTED) (SAGE:DL)
8.68
0.00 (0.00%)
USD |
NASDAQ |
Aug 04, 16:00
Sage Therapeutics Total Liabilities (Quarterly): 54.18M for June 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Supernus Pharmaceuticals, Inc. | 370.09M |
| Biogen, Inc. | 11.00B |
| Eli Lilly & Co. | 91.08B |
| Sarepta Therapeutics, Inc. | 2.173B |
| IGM Biosciences, Inc. (DELISTED) | 6.06M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 422.92M |
| Shareholders Equity (Quarterly) | 368.74M |
| Current Ratio | 9.164 |